Regional brain cytochrome oxidase activity in beta-amyloid precursor protein transgenic mice with the Swedish mutation.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Neuroscience

• Publication date

  2003-06-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0306-4522(03)00037-XPMID 12732258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The mouse brain in stereotaxic coordinates

  2003cited by this paper
• Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice

  2002cited by this paper
• Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation.

  2002cited by this paper
• Neurotoxic Aβ peptides increase oxidative stress in vivo through NMDA‐receptor and nitric‐oxide‐synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro

  2001cited by this paper
• Hippocampal formation glucose metabolism and volume losses in MCI and AD.

  2001cited by this paper
• Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD

  2001cited by this paper
• The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology

  2001cited by this paper
• Reduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease

  2001cited by this paper
• Mitochondrial Abnormalities in Alzheimer's Disease

  2001cited by this paper
• Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy

  2001cited by this paper
• β‐Amyloid inhibits integrated mitochondrial respiration 
and key enzyme activities

  2001cited by this paper
• Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration

  2001cited by this paper
• The neurometabolic landscape of cognitive decline: in vivo studies with positron emission tomography in Alzheimer's disease.

  2000cited by this paper
• Soluble beta-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway.

  2000cited by this paper
• Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway

  2000cited by this paper
• Single and multiple transgenic mice as models for Alzheimer's disease.

  2000cited by this paper
• The cause of neuronal degeneration in Alzheimer's disease.

  2000cited by this paper
• Selective pathological changes of the periaqueductal gray matter in Alzheimer's disease

  2000cited by this paper
• A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.

  2000cited by this paper
• Perfusion abnormalities in prodromal AD.

  2000cited by this paper
• Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms.

  2000cited by this paper
• Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis.

  2000cited by this paper
• Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease.

  2000cited by this paper
• Cerebral Amyloid Induces Aberrant Axonal Sprouting and Ectopic Terminal Formation in Amyloid Precursor Protein Transgenic Mice

  1999cited by this paper
• Expression and regulation of NMDA receptor subunit R1 and neuronal nitric oxide synthase in cortical neuronal cultures: Correlation with cytochrome oxidase

  1999cited by this paper
• Translating cell biology into therapeutic advances in Alzheimer's disease

  1999cited by this paper
• β‐Amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer’s disease

  1999cited by this paper
• An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration.

  1999cited by this paper
• Microglia in Alzheimer's disease and transgenic models. How close the fit?

  1999cited by this paper
• Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F beta-amyloid precursor protein.

  1999cited by this paper
• Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology

  1999cited by this paper
• Histochemically Reactive Zinc in Plaques of the Swedish Mutant β-Amyloid Precursor Protein Transgenic Mice

  1999cited by this paper
• Decreased Brain Protein Levels of Cytochrome Oxidase Subunits in Alzheimer's Disease and in Hereditary Spinocerebella Ataxia Disorders

  1999cited by this paper
• Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain*

  1999cited by this paper
• Transgenic animals relevant to Alzheimer's disease.

  1999cited by this paper
• Microtechnology: Laying it on thick

  1999cited by this paper
• GATA-3 Is Involved in the Development of Serotonergic Neurons in the Caudal Raphe Nuclei

  1999cited by this paper
• SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein

  1999cited by this paper
• Association of microglia with amyloid plaques in brains of APP23 transgenic mice.

  1999cited by this paper
• Functional Brain Imaging in the Resting State and during Activation in Alzheimer's Disease: Implications for Disease Mechanisms Involving Oxidative Phosphorylation

  1999cited by this paper
• Transgenic mouse models of Alzheimer's disease.

  1998cited by this paper
• Neuron loss in APP transgenic mice

  1998cited by this paper
• Regional brain variations of cytochrome oxidase activity and motor coordination in Lurcher mutant mice

  1998cited by this paper
• Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease

  1998cited by this paper
• Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

  1998cited by this paper
• Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease

  1998cited by this paper
• Inherited neurodegenerative diseases and transgenic models.

  1998cited by this paper
• Cybrids in Alzheimer's disease: A cellular model of the disease?

  1997cited by this paper
• Presenilins and Alzheimer's disease.

  1997cited by this paper
• Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

  1997cited by this paper
• Mitochondria and free radicals in neurodegenerative diseases

  1997cited by this paper
• APPSW Transgenic Mice Develop Age‐related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1

  1997cited by this paper
• Molecular aspects of inflammatory and immune responses in Alzheimer's disease.

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Inherited Neurodegenerative Diseases and Transgenic Models

  1996cited by this paper
• Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s Disease

  1996cited by this paper
• Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases.

  1995cited by this paper
• Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins.

  1995cited by this paper
• Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

  1995cited by this paper
• Cytochrome C Oxidase in Alzheimer's Disease Brain

  1995cited by this paper
• Electron transport chain defects in Alzheimer's disease brain

  1994cited by this paper
• Electron transport chain defects in Alzheimer's disease.

  1994cited by this paper
• Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

  1994cited by this paper
• The Olfactory Bulb in Alzheimer Disease: A Morphologic Study of Neuron Loss, Tangles, and Senile Plaques in Relation to Olfaction

  1994cited by this paper
• Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)

  1994cited by this paper
• Quantitative mapping of cytovhrome oxidase activity in the central auditory system of the gerbil: a study with calibrated activity standards and metal-intensified histochemistry

  1994cited by this paper
• Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration.

  1993cited by this paper
• Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons

  1993cited by this paper
• Brain Cytochrome Oxidase in Alzheimer's Disease

  1992cited by this paper
• Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects.

  1991cited by this paper
• Cytochrome oxidase deficiency in Alzheimer's disease

  1990cited by this paper
• Cytochrome oxidase: an endogenous metabolic marker for neuronal activity.

  1989cited by this paper
• The Rat nervous system

  1985cited by this paper
• Cortical connections between rat cingulate cortex and visual, motor, and postsubicular cortices

  1983cited by this paper
• Senile dementia of the Alzheimer type

  1983cited by this paper
• Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry.

  1979cited by this paper
• Subcortical projections to the prefrontal cortex in the rat as revealed by the horseradish peroxidase technique.

  1978cited by this paper
• Ultramicrospectrophotometric determination of cytochrome oxidase for quantitative histochemistry.

  1953cited by this paper

• Direct Conversion of Fibroblast into Neurons for Alzheimer’s Disease Research: A Systematic Review

  2023cites this paper
• Investigating the role of Amyloid Precursor-Like Protein 2 in Motor Neurone Disease

  2019cites this paper
• Impaired cognition and cerebral glucose regulation are associated with astrocyte activation in the parenchyma of metabolically stressed APPswe/PS1dE9 mice.

  2015cites this paper
• Prophylactic melatonin significantly reduces Alzheimer’s neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPPswe/PS1 mice

  2015cites this paper
• Melatonin’s Mitochondrial Protective Role in Alzheimer’s Mice: Role of Melatonin Receptors

  2014cites this paper
• Noradrenergic Deficits Contribute to Impairment in the TgCRND8 Mouse Model of Alzheimer's Disease

  2014cites this paper
• A Generic Research Paradigm for Identification and Validation of Early Molecular Diagnostics and New Therapeutics in Common Disorders

  2012cites this paper
• Induction of apoptotic change in the rat hippocampus caused by ferric nitrilotriacetate

  2011cites this paper
• Early-onset dysfunction of retrosplenial cortex precedes overt amyloid plaque formation in Tg2576 mice.

  2011cites this paper
• Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease

  2011cites this paper
• Amyloid cascade hypothesis

  2011cites this paper
• Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine

  2011cites this paper
• Altered emotionality leads to increased pain tolerance in amyloid beta (Abeta1-40) peptide-treated mice.

  2010cites this paper
• Regional brain metabolism with cytochrome c oxidase histochemistry in a PS1/A246E mouse model of autosomal dominant Alzheimer's disease: correlations with behavior and oxidative stress.

  2009cites this paper
• Effect of gender on mitochondrial toxicity of Alzheimer's Abeta peptide.

  2007cites this paper
• Energy Metabolism is Compromised in Skeletal Muscle of Rats Chronically-Treated with Glutaric Acid

  2007cites this paper
• Differential expression of oxidative phosphorylation genes in patients with Alzheimer’s disease

  2007influential citation
• Effect of Gender on Mitochondrial Toxicity of Alzheimer's Aβ Peptide

  2007cites this paper
• Evaluation der Minimalen Alveolären Konzentration von Isofluran bei zwei transgenen Mausmodellen für die Alzheimer Krankheit

  2007cites this paper
• Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment.

  2006cites this paper
• Amyloid precursor protein‐mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer's disease

  2006cites this paper
• Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: On defects in the cytochrome c oxidase complex and aldehyde detoxification

  2006cites this paper
• Are mitochondria critical in the pathogenesis of Alzheimer's disease?

  2005cites this paper
• Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen.

  2005cites this paper
• Discovery and development of biomarkers of neurological disease.

  2005cites this paper
• Transgenic mice expressing the human C99 terminal fragment of betaAPP: effects on cytochrome oxidase activity in skeletal muscle and brain.

  2004cites this paper
• Biomarker identification in neurologic diseases: improving diagnostics and therapeutics

  2004cites this paper
• Regional brain variations of cytochrome oxidase activity in spontaneously hypertensive mice

  2004cites this paper
• Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease.

  2004cites this paper
• Effects of alpha-tocopherol on an animal model of tauopathies.

  2004cites this paper
• Measurement of Gelatinase B (MMP-9) in the Cerebrospinal Fluid of Patients With Vascular Dementia and Alzheimer Disease

  2004cites this paper
• P3-291 Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage

  2004cites this paper
• P1-227 Gene expression profiles of transcripts in amyloid precursor protein transgenic mice Up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease

  2004cites this paper
• Effects of α-tocopherol on an animal model of tauopathies

  2004cites this paper
• Spatial learning and exploration of environmental stimuli in 24-month-old female APP23 transgenic mice with the Swedish mutation.

  2004cites this paper